C79.62
Secondary malignant neoplasm of left ovary
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the left ovary refers to cancer that has spread to the ovary from another primary site in the body. Unlike primary ovarian cancer, which originates directly in the ovary, this condition results from metastasis—a process where cancer cells travel through the bloodstream or lymphatic system and establish new tumors in the ovary. Recognizing this condition is crucial for appropriate treatment planning and prognosis assessment. Though less common than primary ovarian cancers, secondary neoplasms highlight the importance of understanding cancer progression and metastasis.
Causes & Symptoms
Clinical Causes: Metastatic spread from primary cancers in organs such as the gastrointestinal tract, breast, or other sites Dissemination of cancer cells via bloodstream or lymphatic system Advanced primary cancers that have infiltrated distant sites including the ovary History of previously diagnosed cancer in another part of the body
Key Symptoms: Pelvic or abdominal pain Increase in abdominal girth or bloating Feeling full quickly when eating Unintended weight loss Abdominal or pelvic mass detected during a physical exam Ascites (accumulation of fluid in the abdomen) Changes in bowel or urinary habits
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of imaging tests and laboratory evaluations. Techniques include ultrasonography, computed tomography (CT) scans, and magnetic resonance imaging (MRI) to visualize abdominal and pelvic structures. A biopsy may be performed to confirm the presence of cancer cells and determine their origin. Additionally, blood tests measuring tumor markers such as CA-125 can aid in diagnosis and monitoring. Medical history, including prior cancers, also helps guide diagnosis and treatment decisions.
Treatment Protocols: Surgical removal of ovarian masses and any accessible metastases Chemotherapy to target cancer cells systemically Targeted therapy or immunotherapy if appropriate based on cancer type Supportive care to manage symptoms and improve quality of life Regular follow-up scans and tests to monitor disease progression or response to treatment
Clinical Advice & FAQs
Billing Guidance
Is C79.62 a billable ICD-10 code?
Yes, C79.62 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.62?
Clinical documentation must specify the nature of Secondary malignant neoplasm of left ovary and any associated comorbidities for accurate reporting.
Cite this Clinical Reference